Mirae Asset Global Etfs Holdings Ltd. Exact Sciences Corp Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.9 Billion
- Q4 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Exact Sciences Corp stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 18,955 shares of EXAS stock, worth $788,148. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,955
Previous 21,054
9.97%
Holding current value
$788,148
Previous $1.43 Million
25.68%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding EXAS
# of Institutions
666Shares Held
152MCall Options Held
4.25MPut Options Held
1.89M-
Capital World Investors Los Angeles, CA17.5MShares$729 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA17MShares$708 Million0.02% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$502 Million0.01% of portfolio
-
State Street Corp Boston, MA6.23MShares$259 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.76MShares$240 Million0.04% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $7.36B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...